Clinicaltrials.gov identifier:
NCT05396846 (https://clinicaltrials.gov/show/NCT05396846)
Prevention
Diet and weight loss study for people who are overweight and at increased risk of colorectal cancer
Study Contact Information:
For additional information, please contact: Rob Adwere-Boamah, M.A by phone 734-232-4971 or by email [email protected] or contact the study chair by phone 734-936-4494.
This study will test three different diets in people who are overweight and who have an increased risk of colorectal cancer. The study will look at whether these diets improve eating and possibly lead to weight loss.
Participants will attend study visits in Ann Arbor, Michigan at the start of the study, and at 6 and 12 months. Participants in this study will be randomly divided into three groups. The participant and researchers will not be able to choose which group the participant is in.
Participants will follow one of three eating plans for 12 months:
Group 1 will receive a written pamphlet from the American Institute for Cancer Research about cancer preventative diets.
Group 2 will receive the MyBestGI App and User Manual which will limit the amounts of foods from four groups:
They will also be supported by written educational materials and brief telephone support calls.
Group 3 will receive the MyBestGI App and User Manual which will limit the same four food groups as Group 2 as well as encourage seven food groups (fruits, vegetables, herbs, whole grains, foods high in omega-3 fatty acids, olive oil, legumes or nut butter). They will also be supported by written educational materials and brief telephone support calls.
Michigan
University of Michigan
Ann Arbor, Michigan
Contact: Rob Adwere-Boamah, M.A. 734-232-4971 [email protected]
Contact: Study Chair 734-936-4494
Individuals ages 19 and older who have:
Individuals who do not meet the inclusion criteria defined above and those who:
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.